Response to 'Efficacy and safety of bright light therapy for bipolar depression'
Psychiatry Clin Neurosci
.
2020 Jul;74(7):410-411.
doi: 10.1111/pcn.13010.
Epub 2020 May 9.
Authors
Masahiro Takeshima
1
,
Tomohiro Utsumi
2
,
Yumi Aoki
3
,
Zhe Wang
4
,
Masahiro Suzuki
5
,
Isa Okajima
6
,
Norio Watanabe
7
,
Koichiro Watanabe
8
,
Yoshikazu Takaesu
8
Affiliations
1
Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
2
Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan.
3
Psychiatric & Mental Health Nursing, St. Luke's International University, Tokyo, Japan.
4
Renaissance School of Medicine at Stony Brook University, New York, USA.
5
Department of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.
6
Department of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo, Japan.
7
Department of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
8
Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
PMID:
32388878
DOI:
10.1111/pcn.13010
No abstract available
Publication types
Letter
Comment
MeSH terms
Bipolar Disorder*
Depression
Humans
Phototherapy